Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
4
Taylor Morrison Home
TMHC
5
KB Home
KBH
US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 6.4900
- +0.3100+5.02%
Close Mar 28 16:00 ET
- 6.4900
- 0.00000.00%
Post 20:01 ET
25.77MMarket Cap-5.64P/E (TTM)
6.6300High6.0800Low38.80KVolume6.1200Open6.1800Pre Close245.76KTurnover0.98%Turnover RatioLossP/E (Static)3.97MShares7.890052wk High0.28P/B25.71MFloat Cap2.770052wk Low--Dividend TTM3.96MShs Float21599978.4000Historical High--Div YieldTTM8.90%Amplitude2.7700Historical Low6.3330Avg Price1Lot Size
Tenax Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 136.75%19.49M | 118.34%7.29M | 118.14%4.62M | 197.05%3.67M | 153.88%3.91M | -25.50%8.23M | 30.78%3.34M | -27.42%2.12M | -56.81%1.24M | -43.37%1.54M |
| Selling and administrative expenses | 35.56%6.79M | 64.55%2.7M | 43.30%1.51M | 29.49%1.34M | -3.22%1.23M | -11.81%5.01M | 15.62%1.64M | -23.65%1.05M | -22.37%1.04M | -17.33%1.27M |
| -General and administrative expense | 35.56%6.79M | 64.55%2.7M | 43.30%1.51M | 29.49%1.34M | -3.22%1.23M | -11.81%5.01M | 15.62%1.64M | -23.65%1.05M | -22.37%1.04M | -17.33%1.27M |
| Research and development costs | 293.59%12.71M | 170.29%4.59M | 191.98%3.11M | 1,076.15%2.33M | 906.89%2.68M | -39.95%3.23M | 49.76%1.7M | -30.80%1.07M | -87.02%197.9K | -77.44%265.74K |
| Operating profit | -136.75%-19.49M | -118.34%-7.29M | -118.14%-4.62M | -197.05%-3.67M | -153.88%-3.91M | 25.50%-8.23M | -30.78%-3.34M | 27.42%-2.12M | 56.81%-1.24M | 43.37%-1.54M |
| Net non-operating interest income expense | 311.09%1.89M | 793.90%1.03M | 352.82%658.41K | -26.80%95.69K | -8.34%-7.96K | 10,453.36%460K | 114.94K | 39,187.10%145.4K | 9,300.07%130.73K | -184.11%-7.35K |
| Non-operating interest income | 295.45%1.91M | 776.81%1.03M | 340.97%664.72K | -25.01%104.88K | ---- | --484K | --117.12K | --150.74K | 221,898.41%139.86K | ---- |
| Non-operating interest expense | -4.17%23K | -121.26%-465 | 18.27%6.31K | 0.69%9.19K | 8.34%7.96K | 440.18%24K | --2.19K | 1,334.68%5.34K | 514.96%9.13K | 184.11%7.35K |
| Other net income (expense) | -98.41%1K | 158.21%346 | 171.79%654 | -16.14%117.45K | 585.45%63K | -97.70%134 | -139.75%-911 | 45,279.03%140.06K | ||
| Other non- operating income (expenses) | -98.41%1K | 158.21%346 | ---- | 171.79%654 | -16.14%117.45K | 585.45%63K | -97.70%134 | ---- | -139.75%-911 | 45,279.03%140.06K |
| Income before tax | -128.27%-17.6M | -94.27%-6.27M | -100.84%-3.96M | -223.20%-3.58M | -170.04%-3.8M | 30.20%-7.71M | -26.57%-3.23M | 32.39%-1.97M | 61.33%-1.11M | 48.31%-1.41M |
| Income tax | ||||||||||
| Net income | -128.27%-17.6M | -94.27%-6.27M | -100.84%-3.96M | -223.20%-3.58M | -170.04%-3.8M | 30.20%-7.71M | -26.57%-3.23M | 32.39%-1.97M | 61.33%-1.11M | 48.31%-1.41M |
| Net income continuous Operations | -128.27%-17.6M | -94.27%-6.27M | -100.84%-3.96M | -223.20%-3.58M | -170.04%-3.8M | 30.20%-7.71M | -26.57%-3.23M | 32.39%-1.97M | 61.33%-1.11M | 48.31%-1.41M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -128.27%-17.6M | -94.27%-6.27M | -100.84%-3.96M | -223.20%-3.58M | -170.04%-3.8M | 30.20%-7.71M | -26.57%-3.23M | 32.39%-1.97M | 61.33%-1.11M | 48.31%-1.41M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -128.27%-17.6M | -94.27%-6.27M | -100.84%-3.96M | -223.20%-3.58M | -170.04%-3.8M | 30.20%-7.71M | -26.57%-3.23M | 32.39%-1.97M | 61.33%-1.11M | 48.31%-1.41M |
| Basic earnings per share | 96.30%-1.15 | 84.26%-1.8384 | 97.13%-0.19 | 54.25%-1.83 | 74.21%-3.12 | 94.83%-31.04 | 83.20%-11.68 | 96.28%-6.61 | 97.80%-4 | 93.00%-12.1 |
| Diluted earnings per share | 96.30%-1.15 | 84.26%-1.8384 | 97.13%-0.19 | 54.25%-1.83 | 74.21%-3.12 | 94.83%-31.04 | 83.20%-11.68 | 96.28%-6.61 | 97.80%-4 | 93.00%-12.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call